Use of the Clock Drawing Test and the Rey-Osterrieth Complex Figure Test-copy with convolutional neural networks to predict cognitive impairment.

Clock Drawing Test Cognitive impairment Convolutional neural network Machine learning Rey–Osterrieth Complex Figure Test TensorFlow

Journal

Alzheimer's research & therapy
ISSN: 1758-9193
Titre abrégé: Alzheimers Res Ther
Pays: England
ID NLM: 101511643

Informations de publication

Date de publication:
20 04 2021
Historique:
received: 29 11 2020
accepted: 05 04 2021
entrez: 21 4 2021
pubmed: 22 4 2021
medline: 25 6 2021
Statut: epublish

Résumé

The Clock Drawing Test (CDT) and Rey-Osterrieth Complex Figure Test (RCFT) are widely used as a part of neuropsychological test batteries to assess cognitive function. Our objective was to confirm the prediction accuracies of the RCFT-copy and CDT for cognitive impairment (CI) using convolutional neural network algorithms as a screening tool. The CDT and RCFT-copy data were obtained from patients aged 60-80 years who had more than 6 years of education. In total, 747 CDT and 980 RCFT-copy figures were utilized. Convolutional neural network algorithms using TensorFlow (ver. 2.3.0) on the Colab cloud platform ( www.colab. google.com ) were used for preprocessing and modeling. We measured the prediction accuracy of each drawing test 10 times using this dataset with the following classes: normal cognition (NC) vs. mildly impaired cognition (MI), NC vs. severely impaired cognition (SI), and NC vs. CI (MI + SI). The accuracy of the CDT was better for differentiating MI (CDT, 78.04 ± 2.75; RCFT-copy, not being trained) and SI from NC (CDT, 91.45 ± 0.83; RCFT-copy, 90.27 ± 1.52); however, the RCFT-copy was better at predicting CI (CDT, 77.37 ± 1.77; RCFT, 83.52 ± 1.41). The accuracy for a 3-way classification (NC vs. MI vs. SI) was approximately 71% for both tests; no significant difference was found between them. The two drawing tests showed good performance for predicting severe impairment of cognition; however, a drawing test alone is not enough to predict overall CI. There are some limitations to our study: the sample size was small, all the participants did not perform both the CDT and RCFT-copy, and only the copy condition of the RCFT was used. Algorithms involving memory performance and longitudinal changes are worth future exploration. These results may contribute to improved home-based healthcare delivery.

Sections du résumé

BACKGROUND
The Clock Drawing Test (CDT) and Rey-Osterrieth Complex Figure Test (RCFT) are widely used as a part of neuropsychological test batteries to assess cognitive function. Our objective was to confirm the prediction accuracies of the RCFT-copy and CDT for cognitive impairment (CI) using convolutional neural network algorithms as a screening tool.
METHODS
The CDT and RCFT-copy data were obtained from patients aged 60-80 years who had more than 6 years of education. In total, 747 CDT and 980 RCFT-copy figures were utilized. Convolutional neural network algorithms using TensorFlow (ver. 2.3.0) on the Colab cloud platform ( www.colab.
RESEARCH
google.com ) were used for preprocessing and modeling. We measured the prediction accuracy of each drawing test 10 times using this dataset with the following classes: normal cognition (NC) vs. mildly impaired cognition (MI), NC vs. severely impaired cognition (SI), and NC vs. CI (MI + SI).
RESULTS
The accuracy of the CDT was better for differentiating MI (CDT, 78.04 ± 2.75; RCFT-copy, not being trained) and SI from NC (CDT, 91.45 ± 0.83; RCFT-copy, 90.27 ± 1.52); however, the RCFT-copy was better at predicting CI (CDT, 77.37 ± 1.77; RCFT, 83.52 ± 1.41). The accuracy for a 3-way classification (NC vs. MI vs. SI) was approximately 71% for both tests; no significant difference was found between them.
CONCLUSIONS
The two drawing tests showed good performance for predicting severe impairment of cognition; however, a drawing test alone is not enough to predict overall CI. There are some limitations to our study: the sample size was small, all the participants did not perform both the CDT and RCFT-copy, and only the copy condition of the RCFT was used. Algorithms involving memory performance and longitudinal changes are worth future exploration. These results may contribute to improved home-based healthcare delivery.

Identifiants

pubmed: 33879200
doi: 10.1186/s13195-021-00821-8
pii: 10.1186/s13195-021-00821-8
pmc: PMC8059231
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

85

Références

Cell Syst. 2016 Jan 27;2(1):12-4
pubmed: 27136685
Alzheimers Dement (N Y). 2019 Dec 10;5:918-925
pubmed: 31879701
Sci Rep. 2019 Mar 5;9(1):3543
pubmed: 30837580
J Infect Public Health. 2020 Oct;13(10):1381-1396
pubmed: 32646771
J Am Geriatr Soc. 1986 Jan;34(1):12-9
pubmed: 3941239
Neuropsychologia. 1981;19(3):375-83
pubmed: 7266830
PLoS One. 2018 May 3;13(5):e0195605
pubmed: 29723236
Arthroscopy. 2021 May;37(5):1694-1697
pubmed: 32828936
J Alzheimers Dis. 2020;75(3):717-728
pubmed: 32333585
Mach Learn. 2016 Mar;102(3):393-441
pubmed: 27057085
Medicine (Baltimore). 2020 Apr;99(16):e19620
pubmed: 32311931
J Korean Med Sci. 2010 Jul;25(7):1071-6
pubmed: 20592901
Sensors (Basel). 2020 Oct 23;20(21):
pubmed: 33114070
PLoS One. 2017 Jun 29;12(6):e0179804
pubmed: 28662070
Int J Geriatr Psychiatry. 2000 Jun;15(6):548-61
pubmed: 10861923
Arch Neurol. 2008 Aug;65(8):1091-5
pubmed: 18695059
NPJ Digit Med. 2020 Sep 11;3:118
pubmed: 32984550
Neuropsychiatry Neuropsychol Behav Neurol. 1999 Apr;12(2):95-101
pubmed: 10223256
J Clin Psychol. 1993 Jan;49(1):54-60
pubmed: 8425935
Neuroimage. 2010 Aug 1;52(1):234-44
pubmed: 20382237
Psychogeriatrics. 2018 Mar;18(2):123-131
pubmed: 29417704
Arch Neurol. 2004 Jan;61(1):59-66
pubmed: 14732621
Dement Neurocogn Disord. 2018 Sep;17(3):100-109
pubmed: 30906399
Clin Neuropsychol. 2000 Nov;14(4):551-4
pubmed: 11262724
Proc AAAI Conf Artif Intell. 2014 Jul;2014:2898-2905
pubmed: 27066307
J Clin Neuropsychol. 1982 May;4(1):51-8
pubmed: 7096586
Psychiatry Investig. 2018 Sep;15(9):869-875
pubmed: 30176706
Dement Geriatr Cogn Disord. 2008;26(6):483-9
pubmed: 18987468

Auteurs

Young Chul Youn (YC)

Department of Neurology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea.
Department of Medical Informatics, Chung-Ang University College of Medicine, Seoul, Republic of Korea.

Jung-Min Pyun (JM)

Department of Neurology, Seoul National University College of Medicine & Seoul National University Bundang Hospital, Seoul, Republic of Korea.

Nayoung Ryu (N)

Department of Neurology, Seoul National University College of Medicine & Seoul National University Bundang Hospital, Seoul, Republic of Korea.

Min Jae Baek (MJ)

Department of Neurology, Seoul National University College of Medicine & Seoul National University Bundang Hospital, Seoul, Republic of Korea.

Jae-Won Jang (JW)

Department of Neurology, Kangwon National University Hospital, Kangwon National University College of Medicine, Chuncheon, Republic of Korea.

Young Ho Park (YH)

Department of Neurology, Seoul National University College of Medicine & Seoul National University Bundang Hospital, Seoul, Republic of Korea.

Suk-Won Ahn (SW)

Department of Neurology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea.

Hae-Won Shin (HW)

Department of Neurology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea.

Kwang-Yeol Park (KY)

Department of Neurology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea.
Department of Medical Informatics, Chung-Ang University College of Medicine, Seoul, Republic of Korea.

Sang Yun Kim (SY)

Department of Medical Informatics, Chung-Ang University College of Medicine, Seoul, Republic of Korea. neuroksy@snu.ac.kr.
Department of Neurology, Seoul National University College of Medicine & Neurocognitive Behavior Center, Seoul National University Bundang Hospital, 300 Gumi-dong, Bundang-gu, Seongnam-si, Gyeonggi-do, 463-707, Republic of Korea. neuroksy@snu.ac.kr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH